Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece-Reference-Cited by-同舟云学术

Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece

Published:2017-11-29 Issue: Volume:4 Page:
ISSN:2296-858X
Container-title:Frontiers in Medicine
language:
Short-container-title:Front. Med.

Author:

Tzouvelekis Argyrios,Karampitsakos Theodoros,Ntolios Paschalis,Tzilas Vasilios,Bouros Evangelos,Markozannes Evangelos,Malliou Ioanna,Anagnostopoulos Aris,Granitsas Andreas,Steiropoulos Paschalis,Dimakou Katerina,Chrysikos Serafeim,Koulouris Nikolaos,Bouros Demosthenes

Publisher

Frontiers Media SA

Subject

General Medicine

Reference40 articles.

1. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management;Raghu;Am J Respir Crit Care Med,2011

2. Lung cancer in patients with idiopathic pulmonary fibrosis;Karampitsakos;Pulm Pharmacol Ther,2017

3. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature;Nalysnyk;Eur Respir Rev,2012

4. Incidence and prevalence of idiopathic pulmonary fibrosis;Raghu;Am J Respir Crit Care Med,2006

5. Idiopathic pulmonary fibrosis: on the move;Bouros;Lancet Respir Med,2014

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world safety and effectiveness of pirfenidone and nintedanib in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis;European Journal of Clinical Pharmacology;2024-07-04

2. Real world experience on the effectiveness and safety of pirfenidone in patients with idiopathic pulmonary fibrosis in Taiwan;Frontiers in Medicine;2023-10-30

3. Improvement of psoriatic skin lesions following pirfenidone use in patients with fibrotic lung disease;BMJ Case Reports;2023-09

4. Cinnamic acid mitigates methotrexate-induced lung fibrosis in rats: comparative study with pirfenidone;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-08-15

5. Exploratory phase 2 study of the novel oral multi-kinase inhibitor TAS-115 in patients with idiopathic pulmonary fibrosis;Respiratory Investigation;2023-07